These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 16775949)

  • 1. [Efficacy of a single dose of a vaccine (SA14-14-2) against Japanese encephalitis].
    Diagana M; Ngoungou EB; Preux PM
    Med Trop (Mars); 2006 Apr; 66(2):205. PubMed ID: 16775949
    [No Abstract]   [Full Text] [Related]  

  • 2. Effectiveness of one dose of SA 14-14-2 vaccine against Japanese encephalitis.
    Kumar R; Tripathi P; Rizvi A
    N Engl J Med; 2009 Apr; 360(14):1465-6. PubMed ID: 19339732
    [No Abstract]   [Full Text] [Related]  

  • 3. Single dose of inactivated Japanese encephalitis vaccine with poly(gamma-glutamic acid) nanoparticles provides effective protection from Japanese encephalitis virus.
    Okamoto S; Yoshii H; Ishikawa T; Akagi T; Akashi M; Takahashi M; Yamanishi K; Mori Y
    Vaccine; 2008 Jan; 26(5):589-94. PubMed ID: 18180081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Japanese encephalitis vaccine.
    Dubey AP;
    Indian Pediatr; 2000 Oct; 37(10):1083-4. PubMed ID: 11042706
    [No Abstract]   [Full Text] [Related]  

  • 5. The efficacy of mouse-brain inactivated Nakayama strain Japanese encephalitis vaccine--results from 30 years experience in Taiwan.
    Yang SE; Pan MJ; Tseng HF; Liau MY
    Vaccine; 2006 Mar; 24(14):2669-73. PubMed ID: 16314007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new Japanese encephalitis vaccine (Ixiaro).
    Med Lett Drugs Ther; 2009 Aug; 51(1319):66-7. PubMed ID: 19696707
    [No Abstract]   [Full Text] [Related]  

  • 7. An hsp70 fusion protein vaccine potentiates the immune response against Japanese encephalitis virus.
    Ge FF; Qiu YF; Yang YW; Chen PY
    Arch Virol; 2007 Jan; 152(1):125-35. PubMed ID: 16862385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a single, high-dose vaccination regimen to the standard regimen for the investigational Japanese encephalitis vaccine, IC51: a randomized, observer-blind, controlled Phase 3 study.
    Schuller E; Klade CS; Wölfl G; Kaltenböck A; Dewasthaly S; Tauber E
    Vaccine; 2009 Mar; 27(15):2188-93. PubMed ID: 19200452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expert opinion on vaccination of travelers against Japanese encephalitis.
    Teitelbaum P
    J Travel Med; 2009; 16(6):441; author reply 441-2. PubMed ID: 19930391
    [No Abstract]   [Full Text] [Related]  

  • 10. A new inactivated Japanese encephalitis vaccine for adult travelers.
    Toovey S
    Travel Med Infect Dis; 2009 Sep; 7(5):301-4. PubMed ID: 19747666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Japanese encephalitis].
    Jelinek T
    Dtsch Med Wochenschr; 2002 May; 127(21):1155-6. PubMed ID: 12085312
    [No Abstract]   [Full Text] [Related]  

  • 12. IC51 Japanese encephalitis vaccine.
    Kollaritsch H; Paulke-Korinek M; Dubischar-Kastner K
    Expert Opin Biol Ther; 2009 Jul; 9(7):921-31. PubMed ID: 19527110
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese Encephalitis vaccine IC51 and the hepatitis A vaccine HAVRIX1440 in healthy subjects: A single-blind, randomized, controlled Phase 3 study.
    Kaltenböck A; Dubischar-Kastner K; Eder G; Jilg W; Klade C; Kollaritsch H; Paulke-Korinek M; von Sonnenburg F; Spruth M; Tauber E; Wiedermann U; Schuller E
    Vaccine; 2009 Jul; 27(33):4483-9. PubMed ID: 19486955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single dose of SA 14-14-2 vaccine provides long-term protection against Japanese encephalitis: a case-control study in Nepalese children 5 years after immunization. drjbtandan@yahoo.com.
    Tandan JB; Ohrr H; Sohn YM; Yoksan S; Ji M; Nam CM; Halstead SB
    Vaccine; 2007 Jun; 25(27):5041-5. PubMed ID: 17521781
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Japanese encephalitis: the need for a more effective vaccine.
    Marfin AA; Gubler DJ
    Lancet; 2005 Oct 15-21; 366(9494):1335-7. PubMed ID: 16226596
    [No Abstract]   [Full Text] [Related]  

  • 16. Mucosal vaccination approach against mosquito-borne Japanese encephalitis virus.
    Harakuni T; Kohama H; Tadano M; Uechi G; Tsuji N; Matsumoto Y; Miyata T; Tsuboi T; Oku H; Arakawa T
    Jpn J Infect Dis; 2009 Jan; 62(1):37-45. PubMed ID: 19168957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Japanese encephalitis: is there a need for a novel vaccine?
    Wilder-Smith A; Freedman DO
    Expert Rev Vaccines; 2009 Aug; 8(8):969-72. PubMed ID: 19627179
    [No Abstract]   [Full Text] [Related]  

  • 18. Japanese encephalitis protein vaccine candidates expressing neutralizing epitope and M.T hsp70 induce virus-specific memory B cells and long-lasting antibodies in swine.
    Fei-fei G; Jian W; Feng X; Li-ping S; Quan-yun S; Jin-ping Z; Pu-yan C; Pei-hong L
    Vaccine; 2008 Oct; 26(44):5590-4. PubMed ID: 18761388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular characterization of attenuated Japanese encephalitis live vaccine strain ML-17.
    Shah PS; Tanaka M; Khan AH; Mathenge EG; Fuke I; Takagi M; Igarashi A; Morita K
    Vaccine; 2006 Jan; 24(4):402-11. PubMed ID: 16303214
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Japanese encephalitis vaccination in HIV-infected children with immune recovery after highly active antiretroviral therapy.
    Puthanakit T; Aurpibul L; Yoksan S; Sirisanthana T; Sirisanthana V
    Vaccine; 2007 Nov; 25(49):8257-61. PubMed ID: 17964009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.